Life Line Screening on a Mission to Bring Advanced Bone Density Screening to the Americans

The technology advancement in the healthcare sector has made some significant changes in the way how the treatment is being provided. In the recent years, preventive healthcare has got greater attention due to accurate, scientific, and efficient screening and medication using the advancement of technology innovation. This is what Life Line Screening, a prominent preventive healthcare and screening provider in the United States, is efficiently utilizing the advanced screening and medication options. Recently, the company announced its plans to come up with most-modern bone density screening choices for the people of America by collaborating with Bone Index, Ltd – a leader in medical devices making.

Life Line Screening identified that undiagnosed osteoporosis is a major healthcare challenge across the world. While coming to the United States, it causes nearly two million broken bones per year that costs more than $19 billion in healthcare expenses. A forecast done by medical experts points out that it would bet $25.3 billion by 2025. The biggest challenge in the area is limited early diagnosis options as bone density scans are generally performed in hospitals equipped with DXA X-ray machines, which is highly expensive for the people.

Dr. OssiRiekkinen, the Chief Executive of Bone Index, confirms that this is where Bindex® becomes a real game changer in osteoporosis treatment delivery. He added that Life Line Screening is a leader in wellness and health services in the country with over 15,000 screening events, and that includes ultrasound screening for bone density and vascular disease. The VP of Business Development at Life Line Screening, Kelly Daubach, says that its collaboration with Bone Index helps the wellness screening provider to facilitate convenient and more accurate bone density screening for the people. He also claimed that no other healthcare screening provider could offer safer, accurate, and simplified tests for osteoporosis.

Interestingly, Bindex® is a point-of-care device that screens the cortical bone density of the tibia. Later, the algorithm set in the system calculates the Bone Density Index, which is a parameter in deciding the bone mineral density at the butt measured with DXA. Additionally, Bindex® is a system that holds 19 patents in countries around the world including Japan, China, the United States, and many European countries. Dr. Riekkinen confirmed that Bindex is a widely accepted system across the globe, and it was used in the osteoporosis screening campaign conducted in Finland – the biggest campaign in the world. He continued that Bindex is happy to join hands with Life Line to improve the quality life of Americans.

To Read More : https://www.linkedin.com/company/life-line-screening

Comments are Disabled